Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

CD vs CANG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CD Captures Overall Composite Edge (57.8 HOLD vs 51.3 HOLD), While CANG Leads 3–2 on Growth & Valuation Pillars

CD Overall Winner 6-Pillar Tally: CD 2 – 3 CANG (1 Tie) Matrix Metrics: CD 6 – 4 CANG

As of Nov 19, 2026, CD (CD) captures the overall head-to-head institutional edge over Cango Inc. (CANG) on higher Unified Composite conviction (57.8/100 HOLD vs. 51.3/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while CANG wins 3–2 across the 6-pillar growth and valuation breakdown. CD trades at $3.83 (N/M Forward P/E, -80.5% operating margin) versus CANG at $1.64 (3.1x Forward P/E, -11.1% operating margin).

  • Growth vs. Quality Trade-Off: CD earns the overall head-to-head edge with a stronger Unified Composite Score (57.8/100 HOLD vs. CANG 51.3/100 HOLD) and 2.44β · 160% Vol risk profile, whereas CANG leads top-line expansion (-33.2% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CD vs CANG
CD US Equity Head-to-Head Winner
CD
Institutional Equity
$3.83
-4.73% 1D
Market Cap $442.2M
TTM Revenue $3.4M
Forward P/E N/M
Beta / 30D Vol 2.44β · 160% Vol
Unified Composite Score
57.8 / 100 HOLD
Tech 65.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 37
RSI-14: 36.6 · SMA20: $6.09 · SMA50: $6.14
CANG NYSE
Cango Inc. American Depositary Shares, each representing two (2) Class A Ordinary Shares
Services-Prepackaged Software
$1.64
+10.81% 1D
Market Cap $60.7M
TTM Revenue $557M
Forward P/E 3.1x
Beta / 30D Vol 8.01β · 222% Vol
Unified Composite Score
51.3 / 100 HOLD
Tech 55.0 Fund 51.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.5 · SMA20: $1.32 · SMA50: $2.08

6-Pillar Scorecard Institutional Category Breakdown (CD 2 – 3 CANG)

Columns: Metric · CD · CANG
1. Valuation Multiples CANG
Forward P/E N/M 3.1x
Trailing P/E N/M 3.1x
PEG Ratio N/M N/M
EV / Revenue 128.3x 0.2x
2. Growth & Scale CD
Revenue Growth (YoY) +92.0% -33.2%
Earnings Growth (YoY) +0.0% +137.3%
TTM Revenue (USD) $3.4M $557M
Market Cap $442.2M $60.7M
3. Profitability & Quality CD
Gross Margin 63.1% -5.4%
Operating Margin -80.5% -11.1%
Net Profit Margin -56.0% -107.2%
Return on Equity (ROE) -7.7% -151.0%
4. Balance Sheet & Cash Flow CANG
Cash Generation (TTM) -$4.5M EBITDA $71M EBITDA
Cash Flow Margin -130.3% EBITDA Mgn 12.7% EBITDA Mgn
Net Cash / Leverage $0.56 Book/Sh · -7.7% ROE $26M Net Debt (0.16x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 126.6% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CANG
OpEx & R&D Intensity N/A 5.7% of Rev ($32M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CD (6) vs CANG (4)
Institutional Metric CD CANG Criterion Row Edge
Market Capitalization
Scale
$442.2M $60.7M Larger Scale CD
Trailing P/E Ratio
Valuation
N/M 3.1x Lower Multiple CANG
Forward P/E Ratio
Valuation
N/M 3.1x Lower Multiple CANG
Revenue Growth (YoY)
Growth
+92.0% -33.2% Higher Growth CD
Operating Margin (TTM)
Profitability
-80.5% -11.1% Higher Margin CANG
Net Profit Margin
Profitability
-56.0% -107.2% Higher Margin CD
Return on Equity (ROE)
Capital Efficiency
-7.7% -151.0% Higher ROE CD
52-Week Range Position
Momentum
14% ($2–$14) 37% ($0–$4) Stronger Trend CANG
Beta / 30D Volatility
Risk Regime
2.44β · 160% Vol 8.01β · 222% Vol Lower Realized Risk CD
Unified Institutional Score
Composite Signal
57.8 / 100 (HOLD) 51.3 / 100 (HOLD) Higher Composite CD
Trailing 12M Revenue (USD)
Operating Scale
$3.4M $557M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
63.1% -5.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 128.3x EV/Rev N/M PEG · 0.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$4.5M EBITDA ($0.56 Book/Sh · -7.7% ROE) $71M EBITDA ($26M Net Debt (0.16x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CANG +20.42 pp
CD: -50.03% · CANG: -29.61%
3M Horizon CD +30.05 pp
CD: +6.69% · CANG: -23.36%
6M Horizon CANG +273.65 pp
CD: -59.47% · CANG: +214.18%
1Y Horizon CANG +63.07 pp
CD: -56.58% · CANG: +6.49%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CD vs CANG. Trailing 12-month operating profitability (CD -80.5% vs CANG -11.1%) and valuation multiples (CD N/M vs CANG 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.

CD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.4M
Gross Margin63.1%
Op. Margin-80.5%
ROE / Fwd P/E-7.7% · N/M
CANG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$557M
Gross Margin-5.4%
Op. Margin-11.1%
ROE / Fwd P/E-151.0% · 3.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 126.6%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CANG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CANG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CD Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $442.2M market capitalization and -80.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CANG Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $60.7M market capitalization and -11.1% operating margin.
OpEx & R&D Reinvestment 5.7% of Rev ($32M)
90D Engineering Disclosures 0 Published

Investor FAQ CD vs CANG Key Questions & Quantitative Answers

As of Nov 19, 2026, CD (CD) captures the overall head-to-head institutional edge over Cango Inc. (CANG) on higher Unified Composite conviction (57.8/100 HOLD vs. 51.3/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while CANG wins 3–2 across the 6-pillar growth and valuation breakdown. CD trades at $3.83 (N/M Forward P/E, -80.5% operating margin) versus CANG at $1.64 (3.1x Forward P/E, -11.1% operating margin). Growth vs. Quality Trade-Off: CD earns the overall head-to-head edge with a stronger Unified Composite Score (57.8/100 HOLD vs. CANG 51.3/100 HOLD) and 2.44β · 160% Vol risk profile, whereas CANG leads top-line expansion (-33.2% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

CD leads the Growth & Scale pillar: CD posts +92.0% YoY revenue growth and +0.0% YoY earnings growth on $3.4M TTM revenue (63.1% gross margin, -80.5% operating margin), compared with CANG at -33.2% YoY revenue growth and +137.3% YoY earnings growth on $557M TTM revenue (-5.4% gross margin, -11.1% operating margin). On trailing 12-month operating scale, CD generates $3.4M in USD-normalized revenue versus $557M for CANG. In operating R&D and SG&A reinvestment, CD deploys N/A (0 90-day corporate R&D disclosures) versus 5.7% of Rev ($32M) (0 disclosures) for CANG.

CANG screens cheaper on headline valuation multiples. CD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 128.3x EV/Revenue (-130.3% EBITDA margin), whereas CANG trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.2x EV/Revenue (12.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CD (-7.7% ROE) versus CANG (-151.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CD carries 126.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.44β · 160% Vol realized risk). By comparison, CANG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (8.01β · 222% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.